Insider filing · DRUG

Cormorant Asset Management, LP bought $4.0M of Bright Minds Biosciences (DRUG)

Executed Nov 4 2024, disclosed Nov 6 2024, 2 days later.

Over the 21 trading sessions from the disclosed entry session (Nov 6 2024), the stock returned -31.3% (delay-adjusted); from the execution session (Nov 4 2024), -4.5%. Derived: entry at the session's open, exit at the close 20 sessions later.

CL Cormorant Asset Management, LP Other profile →

Cormorant Asset Management, LP (Other) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 2 sales), most often in DRUG. The largest single filing was $9.8M of DRUG (109,331 sh × $89.50, as filed), executed Apr 28.

DRUG DRUG DRUG · 3 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→